We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Cites Boehringer Ingelheim Contract Manufacturing Subsidiary
FDA Cites Boehringer Ingelheim Contract Manufacturing Subsidiary
December 5, 2007
A decision by Boehringer Ingelheim subsidiary Ben Venue Laboratories to release five finished lots of injectable anesthetic propofol that met product specifications yet significantly exceeded allowed levels of endotoxins during in-process testing has earned the company an FDA warning letter.